Single-use bioprocessing systems offer several advantages beyond cost reduction and increased production flexibility. They also minimize the risk of cross-contamination, ensuring product purity and quality. Additionally, single-use technologies enable rapid scale-up and process optimization, allowing biopharmaceutical companies to bring their products to market more efficiently. As the biopharmaceutical industry continues to expand and evolve, driven by advancements in biotechnology and growing demand for innovative therapies, the adoption of single-use bioprocessing systems is expected to further accelerate, revolutionizing the way biotherapeutics are developed and manufactured.
Market Dynamics:
The global single-use bioprocessing systems market is expected to witness significant growth due to several driving factors, such as growing demand for biologics, shift towards disposable technologies from traditional stainless steel systems, the need for decreased capital expenditure by biopharma companies, and stringent regulatory mandates regarding contamination control. However, market growth can be restricted due to the higher costs associated with single-use components, limited biocompatibility and extractables/leachables issues. The market players have good growth opportunities with the increasing research and development investments in biologics manufacturing, the advancement of single-use bioreactors, and emerging markets offering supportive government initiatives.
Key Features of the Study:
- This report provides an in-depth analysis of the global single-use bioprocessing systems market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global single-use bioprocessing systems market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., Liquidyne, Corning Incorporated, Foxx Life Sciences., PARKER HANNIFIN CORP, Danaher Corporation., Sartorius, GE Healthcare, Eppendorf, Getinge AB, PBS Biotech, Esco Bioengineering, Distek, Bionet and Other Prominent Players
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global Single-use Bioprocessing Systems Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single-use bioprocessing systems market
Detailed Segmentation:
- Global Single-use Bioprocessing Systems Market, By Product Type
- Bioreactors
- Bags and Containers
- Filtration Devices
- Tubing Assemblies and Connectors
- Sensors and Probes
- Others (Accessories & Consumables, etc.)
- Global Single-use Bioprocessing Systems Market, By Application
- Monoclonal Antibody Production
- Vaccine Production
- Cell Therapy
- Viral Vector Production
- Gene Therapy
- Other Biopharmaceutical Production Processes
- Global Single-use Bioprocessing Systems Market, By End User
- Biopharmaceutical Companies
- CROs & CMOs
- Others (Research Labs & Institutes, etc.)
- Global Single-use Bioprocessing Systems Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Top Companies in the Global Single-use Bioprocessing Systems Market:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Liquidyne
- Corning Incorporated
- Foxx Life Sciences.
- PARKER HANNIFIN CORP
- Danaher Corporation.
- Sartorius
- GE Healthcare
- Eppendorf
- Getinge AB
- PBS Biotech
- Esco Bioengineering
- Distek
- Bionet
- Other Prominent Players
